124 related articles for article (PubMed ID: 12354128)
1. Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy.
Nakagawa Y; Mori K; Hoshikawa S; Yamamoto M; Ito S; Yoshida K
Clin Endocrinol (Oxf); 2002 Oct; 57(4):467-71. PubMed ID: 12354128
[TBL] [Abstract][Full Text] [Related]
2. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
Glinoer D; de Nayer P; Bex M;
Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
[TBL] [Abstract][Full Text] [Related]
3. Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease.
Hashizume K; Ichikawa K; Nishii Y; Kobayashi M; Sakurai A; Miyamoto T; Suzuki S; Takeda T
J Clin Endocrinol Metab; 1992 Jul; 75(1):6-10. PubMed ID: 1642700
[TBL] [Abstract][Full Text] [Related]
4. T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
Mastorakos G; Doufas AG; Mantzos E; Mantzos J; Koutras DA
J Endocrinol Invest; 2003 Oct; 26(10):979-84. PubMed ID: 14759070
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
[TBL] [Abstract][Full Text] [Related]
6. Transient recurrence of hyperthyroidism after delivery in Graves' disease.
Amino N; Miyai K; Yamamoto T; Kuro R; Tanaka F
J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228
[TBL] [Abstract][Full Text] [Related]
7. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy.
Rotondi M; Cappelli C; Pirali B; Pirola I; Magri F; Fonte R; Castellano M; Rosei EA; Chiovato L
J Clin Endocrinol Metab; 2008 Oct; 93(10):3985-8. PubMed ID: 18664537
[TBL] [Abstract][Full Text] [Related]
8. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of postpartum Graves' disease.
Lazarus JH; Ludgate ME
Baillieres Clin Endocrinol Metab; 1997 Oct; 11(3):549-60. PubMed ID: 9532339
[TBL] [Abstract][Full Text] [Related]
10. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
Choo YK; Yoo WS; Kim DW; Chung HK
Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease.
Kubota S; Takata K; Arishima T; Ohye H; Nishihara E; Kudo T; Ito M; Fukata S; Amino N; Miyauchi A
Thyroid; 2008 Jan; 18(1):63-6. PubMed ID: 18302519
[TBL] [Abstract][Full Text] [Related]
13. Predicting a relapse of Graves' hyperthyroidism in adults during the early phase of treatment with anti-thyroid drugs.
Jonas M; Ambroziak U; Bednarczuk T; Nauman J
Endokrynol Pol; 2006; 57(6):596-604. PubMed ID: 17253432
[TBL] [Abstract][Full Text] [Related]
14. The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
Kim YA; Cho SW; Choi HS; Moon S; Moon JH; Kim KW; Park DJ; Yi KH; Park YJ; Cho BY
Thyroid; 2017 Apr; 27(4):491-496. PubMed ID: 28001121
[TBL] [Abstract][Full Text] [Related]
15. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Chen JJ; Ladenson PW
J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
[TBL] [Abstract][Full Text] [Related]
16. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Early-Pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-Up Study.
Hou X; Guan H; Sun S; Shi Y; Li C; Liu A; Li Y; Gao X; Hou Y; Yang Y; Li Y; Shan Z; Teng W
Thyroid; 2022 Aug; 32(8):983-989. PubMed ID: 35651276
[No Abstract] [Full Text] [Related]
18. Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
Masiello E; Veronesi G; Gallo D; Premoli P; Bianconi E; Rosetti S; Cusini C; Sabatino J; Ippolito S; Piantanida E; Tanda ML; Chiovato L; Wiersinga WM; Bartalena L
J Endocrinol Invest; 2018 Dec; 41(12):1425-1432. PubMed ID: 29946800
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
Tamai H; Hayaki I; Kawai K; Komaki G; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
